Faslodex Specific Clinical Experience Investigation
Study identifier:D6997C00008
ClinicalTrials.gov identifier:NCT01501266
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Faslodex Specific Clinical Experience Investigation for long-term use
Medical condition
Breast Cancer
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
660
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Feb 2012
Primary Completion Date: 01 Jan 2015
Study Completion Date: 01 Jan 2015
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 May 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Faslodex | - |
Contacts
Investigators
Principal Investigator
Shigeru Yoshida
AstraZeneca KK
